Portage Biotech Inc (PRTG)
NASDAQ:PRTG
US Market

Portage Biotech Inc Stock Price & Analysis

10 Followers

PRTG Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.62 - $16.82
Previous Close$5.84
Volume4.97K
Average Volume (3M)14.95K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$21.18M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-5.0
Beta1.68
Next EarningsJan 02, 2023
Dividend YieldN/A
EPS (TTM)-1.16
Shares Outstanding16,943,672
R-Squared0.00232
Standard Deviation123.30
10 Day Avg. Volume16,047
30 Day Avg. Volume14,952
Price to Book (P/B)-8.21
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)14.10
P/FCF Ratio-54.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside255.99% Upside
Rating ConsensusModerate Buy
Alpha15.11
Number of Analyst Covering1


Financials


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

PRTG FAQ

What was Portage Biotech Inc’s price range in the past 12 months?
Portage Biotech Inc lowest stock price was $4.62 and its highest was $16.82 in the past 12 months.
    What is Portage Biotech Inc’s market cap?
    Currently, no data Available
    When is Portage Biotech Inc’s upcoming earnings report date?
    Portage Biotech Inc’s upcoming earnings report date is Jan 02, 2023 which is in 37 days.
      How were Portage Biotech Inc’s earnings last quarter?
      Currently, no data Available
      Is Portage Biotech Inc overvalued?
      According to Wall Street analysts Portage Biotech Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Portage Biotech Inc pay dividends?
        Portage Biotech Inc pays a Notavailable dividend of $47.4 which represents an annual dividend yield of N/A. Portage Biotech Inc’s last Notavailable dividend payment was on Jan 15, 2018. Portage Biotech Inc’s upcoming ex-dividend date is Jan 04, 2018
          What is Portage Biotech Inc’s EPS estimate?
          Portage Biotech Inc’s EPS estimate is -$0.29.
            How many shares outstanding does Portage Biotech Inc have?
            Portage Biotech Inc has 16,943,672 shares outstanding.
              What happened to Portage Biotech Inc’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Portage Biotech Inc?
              Currently, no hedge funds are holding shares in PRTG

              ---

              Portage Biotech Inc Stock Smart Score

              2
              Underperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -65.62%
              12-Months-Change

              Fundamentals

              Return on Equity
              -12.51%
              Trailing 12-Months
              Asset Growth
              -3.79%
              Trailing 12-Months
              The Portage Biotech Inc stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Portage Biotech Inc

              Portage Biotech, Inc. is engaged in researching & developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs and orphan drugs. It sells and licenses the products to large pharmaceutical companies for further development and commercialization. The company was founded in 1973 and is headquartered in Toronto, Canada.

              ---

              Forecast EPS vs Actual EPS

              Currently, no data available
              Please return soon. This page is being updated.

              Similar Stocks
              Company
              Price & Change
              Follow
              Xenon
              Aurinia Pharmaceuticals
              Repare Therapeutics
              Zymeworks

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis